These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 29117942)

  • 1. ERβ Sensitizes NSCLC to Chemotherapy by Regulating DNA Damage Response.
    Nikolos F; Thomas C; Bado I; Gustafsson JÅ
    Mol Cancer Res; 2018 Feb; 16(2):233-242. PubMed ID: 29117942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ERβ regulates NSCLC phenotypes by controlling oncogenic RAS signaling.
    Nikolos F; Thomas C; Rajapaksa G; Bado I; Gustafsson JÅ
    Mol Cancer Res; 2014 Jun; 12(6):843-54. PubMed ID: 24618619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen receptor β1 activation accelerates resistance to epidermal growth factor receptor-tyrosine kinase inhibitors in non-small cell lung cancer.
    Fu S; Liu C; Huang Q; Fan S; Tang H; Fu X; Ai B; Liao Y; Chu Q
    Oncol Rep; 2018 Mar; 39(3):1313-1321. PubMed ID: 29328407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resveratrol Enhances Etoposide-Induced Cytotoxicity through Down-Regulating ERK1/2 and AKT-Mediated X-ray Repair Cross-Complement Group 1 (XRCC1) Protein Expression in Human Non-Small-Cell Lung Cancer Cells.
    Ko JC; Syu JJ; Chen JC; Wang TJ; Chang PY; Chen CY; Jian YT; Jian YJ; Lin YW
    Basic Clin Pharmacol Toxicol; 2015 Dec; 117(6):383-91. PubMed ID: 26046675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cisplatin resistance in non-small cell lung cancer cells is associated with an abrogation of cisplatin-induced G2/M cell cycle arrest.
    Sarin N; Engel F; Kalayda GV; Mannewitz M; Cinatl J; Rothweiler F; Michaelis M; Saafan H; Ritter CA; Jaehde U; Frötschl R
    PLoS One; 2017; 12(7):e0181081. PubMed ID: 28746345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Xanthatin triggers Chk1-mediated DNA damage response and destabilizes Cdc25C via lysosomal degradation in lung cancer cells.
    Tao L; Cao Y; Wei Z; Jia Q; Yu S; Zhong J; Wang A; Woodgett JR; Lu Y
    Toxicol Appl Pharmacol; 2017 Dec; 337():85-94. PubMed ID: 29074359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ERβ decreases the invasiveness of triple-negative breast cancer cells by regulating mutant p53 oncogenic function.
    Bado I; Nikolos F; Rajapaksa G; Gustafsson JÅ; Thomas C
    Oncotarget; 2016 Mar; 7(12):13599-611. PubMed ID: 26871946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The checkpoint 1 kinase inhibitor LY2603618 induces cell cycle arrest, DNA damage response and autophagy in cancer cells.
    Wang FZ; Fei HR; Cui YJ; Sun YK; Li ZM; Wang XY; Yang XY; Zhang JG; Sun BL
    Apoptosis; 2014 Sep; 19(9):1389-98. PubMed ID: 24928205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CLPTM1L induces estrogen receptor β signaling-mediated radioresistance in non-small cell lung cancer cells.
    Li H; Che J; Jiang M; Cui M; Feng G; Dong J; Zhang S; Lu L; Liu W; Fan S
    Cell Commun Signal; 2020 Sep; 18(1):152. PubMed ID: 32943060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dasatinib induces DNA damage and activates DNA repair pathways leading to senescence in non-small cell lung cancer cell lines with kinase-inactivating BRAF mutations.
    Peng S; Sen B; Mazumdar T; Byers LA; Diao L; Wang J; Tong P; Giri U; Heymach JV; Kadara HN; Johnson FM
    Oncotarget; 2016 Jan; 7(1):565-79. PubMed ID: 26623721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RAD52 motif‑containing protein 1 promotes non‑small cell lung cancer cell proliferation and survival via cell cycle regulation.
    Xu G; Du J; Wang F; Zhang F; Hu R; Sun D; Shen J
    Oncol Rep; 2018 Aug; 40(2):833-840. PubMed ID: 29845285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen receptor beta decreases survival of p53-defective cancer cells after DNA damage by impairing G₂/M checkpoint signaling.
    Thomas CG; Strom A; Lindberg K; Gustafsson JA
    Breast Cancer Res Treat; 2011 Jun; 127(2):417-27. PubMed ID: 20623183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-expression of estrogen receptor beta and aromatase in Japanese lung cancer patients: gender-dependent clinical outcome.
    Verma MK; Miki Y; Abe K; Nagasaki S; Niikawa H; Suzuki S; Kondo T; Sasano H
    Life Sci; 2012 Oct; 91(15-16):800-8. PubMed ID: 22982181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcein-acetoxymethy ester enhances the antitumor effects of doxorubicin in nonsmall cell lung cancer by regulating the TopBP1/p53RR pathway.
    Lv Y; Liu R; Xie S; Zheng X; Mao J; Cai Y; Chen W
    Anticancer Drugs; 2017 Sep; 28(8):861-868. PubMed ID: 28628491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inducible upregulation of oestrogen receptor-beta1 affects oestrogen and tamoxifen responsiveness in MCF7 human breast cancer cells.
    Murphy LC; Peng B; Lewis A; Davie JR; Leygue E; Kemp A; Ung K; Vendetti M; Shiu R
    J Mol Endocrinol; 2005 Apr; 34(2):553-66. PubMed ID: 15821116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-181a and miR-630 regulate cisplatin-induced cancer cell death.
    Galluzzi L; Morselli E; Vitale I; Kepp O; Senovilla L; Criollo A; Servant N; Paccard C; Hupé P; Robert T; Ripoche H; Lazar V; Harel-Bellan A; Dessen P; Barillot E; Kroemer G
    Cancer Res; 2010 Mar; 70(5):1793-803. PubMed ID: 20145152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of miR-25 modulates non-small cell lung cancer cells by targeting CDC42.
    Yang T; Chen T; Li Y; Gao L; Zhang S; Wang T; Chen M
    Tumour Biol; 2015 Mar; 36(3):1903-11. PubMed ID: 25432132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allyl isothiocyanate induces replication-associated DNA damage response in NSCLC cells and sensitizes to ionizing radiation.
    Tripathi K; Hussein UK; Anupalli R; Barnett R; Bachaboina L; Scalici J; Rocconi RP; Owen LB; Piazza GA; Palle K
    Oncotarget; 2015 Mar; 6(7):5237-52. PubMed ID: 25742788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Class III beta-tubulin mediates sensitivity to chemotherapeutic drugs in non small cell lung cancer.
    Gan PP; Pasquier E; Kavallaris M
    Cancer Res; 2007 Oct; 67(19):9356-63. PubMed ID: 17909044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting apoptosis by 1,2-diazole through regulation of EGFR, Bcl-2 and CDK-2 mediated signaling pathway in human non-small cell lung carcinoma A549 cells.
    Vinod Prabhu V; Elangovan P; Niranjali Devaraj S; Sakthivel KM
    Gene; 2018 Dec; 679():352-359. PubMed ID: 30218747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.